SBC Medical Group Holdings Incorporated
SBC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Revenue | $0 | $0 | $0 |
| % Growth | 6.1% | 11.1% | – |
| Cost of Goods Sold | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 |
| % Margin | 76% | 70.9% | 65.9% |
| R&D Expenses | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 |
| Operating Income | $0 | $0 | $0 |
| % Margin | 34.2% | 36.5% | 11.6% |
| Other Income/Exp. Net | $0 | $0 | $0 |
| Pre-Tax Income | $0 | $0 | $0 |
| Tax Expense | $0 | $0 | $0 |
| Net Income | $0 | $0 | $0 |
| % Margin | 22.7% | 20.3% | 3.6% |
| EPS | 0.483 | 0.418 | 0.037 |
| % Growth | 15.5% | 1,039% | – |
| EPS Diluted | 0.483 | 0.418 | 0.037 |
| Weighted Avg Shares Out | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 |
| Supplemental Information | – | – | – |
| Interest Income | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 |
| EBITDA | $0 | $0 | $0 |
| % Margin | 37.6% | 44.4% | 17% |